Elevated levels of inflammatory markers, such as C-reactive protein (CRP), interleukin (IL)-6, and procalcitonin, have been associated with disease severity and poor outcomes in COVID-19 patients [4,5]. This evidence concerns the gene CRP and COVID-19.